Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy

Nature Medicine

Volumn 5, Issue 3, 1999, Pages 320-326

  Badorff, Cornel ^a   Lee, Gil Hwan ^a   Lamphear, Barry J ^b   Martone, Maryann E ^c   Campbell, Kevin P ^d   Rhoads, Robert E ^b   Knowlton, Kirk U ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; DYSTROPHIN; PROTEINASE; SARCOGLYCAN; VIRUS ENZYME;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; COXSACKIE VIRUS; CYTOSKELETON; HEART DILATATION; HEART MUSCLE CELL; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS MYOCARDITIS;

ANIMALS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; CYSTEINE ENDOPEPTIDASES; CYTOSKELETAL PROTEINS; CYTOSKELETON; DYSTROGLYCANS; DYSTROPHIN; ENTEROVIRUS B, HUMAN; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, SCID; MYOCARDIUM; RATS; SARCOLEMMA; VIRAL PROTEINS;

ANIMALIA; COXSACKIEVIRUS; ENTEROVIRUS;

EID: 0033017374     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/6543     Document Type: Article

References (45)

1. Schocken, D.D., Arrieta, M.I., Leaverton, P.E. & Ross, E. A. Prevalence and mortality rate of congestive heart failure in the United States. J. Am. Coll. Cardiol. 20, 301-306 (1992).
2. Cohn, J.N. et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95, 766-770 (1997).
3. Dargie, H.J., McMurray, J.J. & McDonagh, T.A. Heart failure - implications of the true size of the problem. J. Intern. Med. 239, 309-315 (1996).
4. Baboonian, C., Davies, M.J., Booth, J.C. & McKenna, W.J. Coxsackie B viruses and human heart disease. Curr. Top. Microbiol. Immunol. 223, 31-52 (1997).
5. Sole, M.J. & Liu, P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J. Am. Coll. Cardiol. 22, 99A-105A (1993).
6. Leiden, J.M. The genetics of dilated cardiomyopathy emerging clues to the puzzle. N. Engl. J. Med. 337, 1080-1081 (1997).
7. Towbin, J.A. The role of cytoskeletal proteins in cardiomyopathies. Curr. Opin. Cell Biol. 10, 131-139 (1998).
8. Malhotra, S. B. et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242, 755-759 (1988).
9. Beggs, A.H. Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy. Circulation 95, 2344-2347 (1997).
10. Berko, B.A. & Swift, M. X-linked dilated cardiomyopathy. N. Engl. J. Med. 316, 1186-91 (1987).
11. Towbi, J.A. et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy locus. Circulation 87, 1854-1865 (1993).
12. Muntoni, F. et al. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329, 921-5 (1993).
13. Olson, T.M., Michels, V.V., Thibodeau, S.N., Tai, Y. S. & Keating, M.T. Actin mutations in dilated cardiomyopathy, an inheritable form of heart failure. Science 280, 750-752 (1998).
14. Maeda, M., Holder, E., Lowes, B., Valent, S. & Bies, R.D. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95, 17-20 (1997).
15. Fadic, R. et al. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N. Engl. J. Med. 334, 362-6 (1996).
16. Nigro, V. et al. Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6, 601-607 (1997).
17. Grady, R.M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729-738 (1997).
18. Arber, S. et al. MLP-delicient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393-403 (1997).
19. Wessely, R., Henke, A., Zell, R., Kandolf, R. & Knowlton, K.U. Low level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98, 450-457 (1998).
20. Wessely, R. et al. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102, 1444-1453 (1998).
21. Rueckert, R. R. in Fundamental Virology Vol. 3 (eds. Fields, BN., Knipe, D.M. & Howley, P.M.) 477-522 (Raven, New York, 1996).
22. Gradi, A et al. A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell Biol. 18, 334-342 (1998).
23. Lamphear, B.J. et al. Mapping of the cleavage site in protein synthesis initiation factor elF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J. Biol. Chem. 268, 19200-19203 (1993).
24. Blom, N., Hansen, J., Blaas, D. & Brunak, S. Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci. 5, 2203-2216 (1996).
25. Sheng, Z. et al. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J. Biol. Chem. 272, 5783-5791 (1997).
26. Setoguchi, M. et al. Expression and localization of dystrophin in cultured neonatal rat cardiac myocytes. Biocbem. Biophys. Res. Commun. 194, 1012-1018 (1993).
27. Ervasti, J.M., Kahl, S.D. & Campbell, K.P. Purification of dystrophin from skeletal muscle. J. Biol. Chem. 266, 9161-9165 (1991).
28. Chow, L.H., Beisel, K.W. & McManus, B.M. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66, 24-31 (1992).
29. Henke, A., Huber, S., Stelzner, A. & Whitton, J.L. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69, 6720-6728 (1995).
30. Straub, V., Rafael, J.A., Chamberlain, J.S. & Campbell, K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375-385 (1997).
31. Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M. G. & Campbell, K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315-9 (1990).
32. Straub, V. & Campbell, K.P. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168-175 (1997).
33. Rybakova, I.N. & Ervasti, J.M. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J. Biol. Chem. 272, 28771-28778 (1997).
34. Roberts, R.G. & Bobrow, M. Dystrophins in vertebrates and invertebrates. Hum. Mol. Genet. 7, 589-595 (1998).
35. Koenig, M. & Kunkel, L.M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 265, 4560-4566 (1990).
36. Chen, P.H., Ornelles, D.A. & Shenk, T. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 67, 3507-3514 (1993).
37. Shoeman, R.L. et al. Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. Am. J. Pathol. 142, 221-230 (1993).
38. Knowlton, K.U., Jeon, E.S., Berkley, N., Wessely, R. & Huber, S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of CVB3. J. Virol. 70 (11), 7811-7818 (1996).
39. Schwimmbeck, P.L., Badorff, C., Schultheiss, H.P. & Strauer, B.E. Transfer of human myocarditis into severe combined immunodeficiency mice. Circ Res. 75, 156-164 (1994).
40. Bader, D., Masaki, T. & Fischman, D.A. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763-770 (1982).
41. Nicholson, L.V. et al. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J. Neurol. Sci. 94, 125-136 (1989).
42. Morris, G.E. et al. An epitope structure for the C-terminal domain of dystrophin and utrophin. Biochemistry 37, 11117-11127 (1998).
43. Spencer, M.J., Walsh, C.M., Dorshkind, K.A., Rodriguez, E.M. & Tidball, J.G. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Invest. 99, 2745-2751 (1997).
44. Sommergruber, W. et al. Mutational analyses support a model for the HRV2 2A proteinase. Virology 234, 203-214 (1997).
45. Schwarz, E.M. et al. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J. Virol. 72, 5654-5660 (1998).